EGFR and non-small cell lung carcinoma: The survival times of advanced NSCLC patients with EGFR mutation who have CYFRA 21 − 1 positive with Ki67 high were not significantly lower than patients with CYFRA 21 − 1 positive and Ki67 low (p = 0.1146; Supplementary material 1 A).